A carregar...
Insulin degludec as an ultralong-acting basal insulin once a day: a systematic review
BACKGROUND: Insulin degludec (IDeg) is a neutral, ultralong-acting new generation basal insulin analog developed by NovoNordisk currently in Phase III clinical development. IDeg offers a duration of action of more than 42 hours in adults, much longer than current basal insulin formulations. OBJECTIV...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3402007/ https://ncbi.nlm.nih.gov/pubmed/22826637 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DMSO.S21979 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|